Sofinnova Investments, Inc.

Q1 2024 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Nathalie Auber - Attorney-in-Fact
Location
Menlo Park, CA
Holdings as of
31 Mar 2024
Value $
$1,694,515,067
Num holdings
67
Filing time
14 Aug 2024, 14:30:59 UTC
Form type
13F-HR/A-1 - Restatement
Description
All US holdings of this investor are reported in this report. Top holdings included NTRA, VERA, ASND, AVTE, and MRK.
Previous filing
Q4 2023 - 15 Aug 2024
Next filing
Q2 2024 - 09 Aug 2024
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2024 Q1 - Restatement compared to 2023 Q4 - Restatement by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Nathalie Auber Attorney-in-Fact Menlo Park, California 14 Aug 2024

*Sofinnova Investments, Inc. is filing this Form 13F on behalf of itself and the general partner entities of the investment funds for which it serves as the investment adviser, Sofinnova Management VII, L.L.C., Sofinnova Management VIII, L.L.C., Sofinnova Management IX, L.L.C., Sofinnova Management X, L.L.C., Sofinnova BioEquities GP LLC, and Sofinnova Synergy GP LLC.